ArticleTranslational lung cancer research2026
Prognostic impact of smoking in non-small cell lung cancer: histology-specific findings from a retrospective cohort study.
Article in Translational lung cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Smoking negatively influences postoperative outcomes in non-small cell lung cancer (NSCLC), but its prognostic effect may differ by histologic subtype. However, whether this impact varies between adenocarcinoma (ADC) and squamous cell carcinoma (SqCC) remains poorly understood. We aimed to quantify this difference using a pre-specified interaction analysis. Methods: We retrospectively analyzed 8,103 patients who underwent curative-intent resection for pathologic stage I-III NSCLC between 2011 and 2022. Smoking status was categorized as never versus ever (smoking history). Overall survival (OS) and recurrence-free survival (RFS) were evaluated using multivariable Cox models with a smoking × histology interaction term and additional stage-stratified analyses. Results: In the primary multivariable interaction model, smoking history was associated with worse OS in the reference ADC subgroup [hazard ratio (HR): 1.33; 95% confidence interval (CI): 1.10-1.60; P=0.003]. Histology-specific analysis showed that smoking history was associated with worse OS in ADC subgroup (HR: 1.24; 95% CI: 1.02-1.50; P=0.03), whereas in SqCC subgroup, the estimate was imprecise and binary smoking history did not clearly discriminate prognosis (HR: 1.01; 95% CI: 0.67-1.50; P=0.98). The smoking × histology interaction for OS was not significant (interaction HR: 0.74; 95% CI: 0.50-1.09; P=0.12). Conclusions: Smoking history was associated with worse postoperative OS, with the most consistent prognostic signal observed in ADC subgroup. In SqCC cohort, binary smoking history showed limited prognostic discrimination, likely reflecting near-universal smoking exposure rather than absence of biological relevance. Smoking status should be interpreted within histologic context during postoperative risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.